Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(20%)
Results Posted
14%(1 trials)

Phase Distribution

Ph early_phase_1
1
10%
Ph not_applicable
7
70%
Ph phase_1
1
10%
Ph phase_2
1
10%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
1(10.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (10.0%)
Phase 11 (10.0%)
Phase 21 (10.0%)
N/A7 (70.0%)

Trials by Status

recruiting220%
withdrawn110%
completed770%

Recent Activity

2 active trials
Showing 5 of 10
recruitingphase_1

Prebiotic Galacto-oligosaccharide and Acute GVHD

NCT04373057
recruitingnot_applicable

Effect of a Sugar Replacement on Blood Glucose Levels in Healthy Adults

NCT06714552
completednot_applicable

At Home Placebo-controlled 8-week GOS Intervention on Emotion Behaviour and Cognition in Children (Age 6-14 Years).

NCT06258135
completednot_applicable

Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults

NCT02355210
completedearly_phase_1

Galactooligosaccharide (GOS) Supplementation and Calcium Absorption in Girls

NCT01263847
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04373057Phase 1

Prebiotic Galacto-oligosaccharide and Acute GVHD

Recruiting
NCT06714552Not Applicable

Effect of a Sugar Replacement on Blood Glucose Levels in Healthy Adults

Recruiting
NCT06258135Not Applicable

At Home Placebo-controlled 8-week GOS Intervention on Emotion Behaviour and Cognition in Children (Age 6-14 Years).

Completed
NCT02355210Not Applicable

Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults

Completed
NCT01263847Early Phase 1

Galactooligosaccharide (GOS) Supplementation and Calcium Absorption in Girls

Completed
NCT02271776Not Applicable

GOS and Insulin Sensitivity

Completed
NCT02953691Phase 2

Exploring the Impact of Perioperative Galacto-Oligosaccharides (GOS) on Stress, Anxiety and Cognition

Withdrawn
NCT02077088Not Applicable

Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants

Completed
NCT01137760Not Applicable

Galactooligosaccharide, Immune Strength, and Digestive Health

Completed
NCT01302561Not Applicable

Galactooligosaccharide, Immune Strength, and Digestive Health in Older Adults Over Cold and Flu Season

Completed

All 10 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10